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ABSTRACT 
 
Intercalated cells in the collecting duct system express V-type H+-ATPases which 
participate in acid extrusion, bicarbonate secretion, and chloride absorption 
depending on the specific subtype. The activity of H+-ATPases is regulated by acid-
base status and several hormones, including angiotensin II and aldosterone. 
Angiotensin II stimulates chloride absorption mediated by pendrin in type B 
intercalated cells and this process is  energized by the activity of H+-ATPases. 
Moreover, angiotensin II stimulates bicarbonate secretion by the connecting tubule 
(CNT) and early cortical collecting duct (CCD). In the present study  we examined the 
effect of angiotensin II (10 nM) on H+-ATPase activity and localization in isolated 
mouse connecting tubules and cortical collecting ducts. Angiotensin II stimulated 
Na+-independent intracellular pH recovery about 2-3 fold, and this was abolished by 
the specific H+-ATPase inhibitor concanamycin. The effect of angiotensin II was 
mediated through type 1 angiotensin II receptors (AT1-receptors) because it could be 
blocked by saralasin. Stimulation of H+-ATPase activity required an intact 
microtubular network - it was completely inhibited by colchicine. 
Immunocytochemistry of isolated CNT/CCDs incubated in vitro with angiotensin II 
suggests enhanced membrane associated staining of H+-ATPases in pendrin 
expressing intercalated cells. In summary, angiotensin II stimulates H+-ATPases in 
CNT/CCD intercalated cells, and may contribute to the regulation of chloride 
absorption and bicarbonate secretion in this nephron segment.  
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INTRODUCTION 
 
Vacuolar type H+-ATPases are expressed along the entire nephron in various 
cell types and are involved in proton secretion into the urine thereby promoting 
bicarbonate reabsorption in the proximal tubule and thick ascending limb of Henle [1-
2]. In the segments of the collecting duct system (e.g. connecting tubule, cortical and 
medullary collecting ducts), H+-ATPases are abundant in intercalated cells and can 
be found at the luminal, basolateral, or both membranes depending on the subtype of 
intercalated cells [1, 3]. In type A intercalated cells, H+-ATPases are found at the 
luminal membrane secreting protons into urine and thereby energizing ammonium 
secretion and bicarbonate regeneration [1]. These cells are characterized by the 
additional presence of the basolateral chloride/bicarbonate exchanger AE1 [3-4]. In 
contrast, in non-type A intercalated cells (i.e. type B and non-A/non-B intercalated 
cells), H+-ATPases can be localized at the luminal, basolateral or both membranes 
and act in concert with the apical chloride/bicarbonate exchanger pendrin [1, 3, 5]. 
Several subtypes of non-type A intercalated cells may exist but all forms express 
pendrin and vary with respect to their subcellular distribution of H+-ATPases [6-7]. 
Non-type A intercalated cells mediate bicarbonate secretion (in the absence of 
luminal H+-ATPases) and reabsorb chloride (independently of the subcellular 
distribution of H+-ATPases). 
 
The activity of intercalated cells is tightly regulated by a variety of factors 
including acid-base status, dietary electrolyte intake, and various hormones including 
angiotensin II, aldosterone, and endothelin [3]. Angiotensin II is a potent regulator of 
urinary acidification in vivo [8-11] and has been shown by us and others to stimulate 
H+-ATPase activity in proximal tubule cells [12], type A intercalated cells in the outer 
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medullary collecting ducts [13-14], and renal cell lines [15-17]. Recent studies by 
Pech and Wall demonstrated that angiotensin II stimulates chloride absorption in 
isolated mouse cortical collecting ducts. Chloride absorption was dependent on the 
presence of pendrin and blocked by an H+-ATPase inhibitor suggesting that H+-
ATPases in non-type A intercalated cells may also be stimulated by angiotensin II 
[18]. Along the same lines, angiotensin II enhances bicarbonate secretion in rabbit 
early cortical collecting ducts [19]. Taken together, these observations suggest that 
angiotensin II may have a direct stimulatory effect on H+-ATPases in type B 
intercalated cells and may thereby drive bicarbonate secretion and chloride 
absorption. 
 
We examined in the present study whether angiotensin II directly stimulates 
H+-ATPase activity in isolated mouse cortical collecting duct intercalated cells; which 
receptor subtype may be involved, and whether locally produced angiotensin II may 
participate in the regulation of H+-ATPases. Our results reveal a potent stimulation of 
H+-ATPases by angiotensin II via AT1 receptors and suggest that stimulated H+-
ATPases may be important for type B intercalated cell function. 
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MATERIALS AND METHODS 
 
Animals 
Male C57Bl/6J mice (Jackson Laboratories, Bar Harbor, ME, USA), 12-14 
weeks old,  were kept under standard conditions with free access to food and water. 
The generation, breeding, and genotyping of mice expressing eGFP under the 
control of the B1 H+-ATPase (ATP6V1B1) promoter has been described previously 
[20]. B1-eGFP mice were kindly provided by Dr. Lance Miller and Rauol Nelson, 
University of Utah, Salt Lake City, USA, and bred in Zurich. 
The use of mice was according to local Animal Welfare Laws and approved by the 
Yale University Committee for the Use of Animals and the Zurich Veterinary Office 
(Kantonales Veterinäramt). 
 
Preparation of isolated cortical collecting duct fragments and intracellular pH 
measurements 
C57Bl/6J mice were sacrificed with pentobarbital (150 mg/kg), both kidneys 
removed and transferred into ice-cold HEPES solution. After the removal of the 
capsula, vessels and pelvis, the kidneys were cut into slices 2-3 mm in thickness. 
The cortex was prepared under a stereo microscope (5x magnification) and the 
cortical slices were then incubated in a digestion solution (4 ml Minimum Essential 
Medium, 5 mM glycine, 6 mg/ ml trypsin inhibitor, and 250 µg/ml collagenase 
(Sigma)) at 37 °C in a water bath for 15 min. After 15 min the digestion was stopped 
by transferring the tubules onto ice, gently removing the supernatant and replacing it 
with 4 ml ice-cold 1 % BSA HEPES solution. The BSA HEPES solution was replaced 
by ice-cold HEPES solution after 10 min and tubules kept on ice for the experiments. 
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Cortical collecting ducts were selected under the preparation microscope and 
transferred to a perfusion chamber containing coverslips precoated with the cell-
adhesive Cell-Tak (Becton-Dickinson). The temperature of the chamber was 
maintained at 37 ± 0.5 °C by an electronic feedback circuit. The control bath solution 
was initially a HEPES solution (sol. 1), flowing continuously at ≈ 3 ml/ min. The 
chamber volume was ≈ 180 µl. Single tubule fragments were loaded with the pH-
sensitive dye 2’,7’-bis(2carboxylethyl)-5(6)-carboxyflourescein (BCECF) (10 µM) for 
20 min at room temperature as described [12, 21-23]. pHi was measured 
microflourometrically by alternately exciting the dye with a 10 µm diameter spot of 
light at 440 and 490 nm while monitoring the emission at 532 nm [12, 21-23]. Each 
experiment was calibrated for pHi using the nigericin/ high K+ method [24] that 
converted the  obtained ratios  to pHi. 
The solutions used are given in table 1. H+-ATPase activity was measured as 
described previously [12, 14, 21-23, 25-28]. Briefly, bicarbonate free solutions were 
used and Na+ removed to abolish Na+/H+ exchanger activity. For these experiments 
Na+ was replaced by equimolar amounts of NMDG (N-Methyl-D-Glucamine). To 
induce a strong intracellular acidification and elicit H+-ATPase activation, NH4Cl 
pulses were performed in the absence of Na+ as described previously [22, 29]. All 
chemicals were obtained from Sigma. Stimulators and inhibitors were added to the 
BCECF incubation solution and all other solutions at the concentrations stated. 
 
Immunostaining 
Tubules were prepared as described above, eGFP positive CNT/CCD 
fragments collected under a dissection microscope equipped with a fluorescent lamp, 
and staining was performed as described previously [22].  Briefly, isolated tubules 
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were transferred onto cover-slips precoated with Cell-Tak and allowed to adhere for 
15 min. Next, isolated tubules were incubated with 10 nM Angiotensin II for 15 min at 
37°C and then fixed with 2 % paraformaldehyde in PBS for 5 min at room 
temperature, tubules were washed 3 times with PBS, permeabilized with 0.1% Triton 
X, washed twice with PBS, treated with 1% SDS [30], washed 3 times with PBS, and 
incubated with PBS containing 1% bovine serum albumin for 15 min prior to addition 
of the primary antibodies. The primary antibodies were diluted in PBS and applied 
overnight at 4 °C: guinea-pig anti-mouse pendrin (1:2000 raw serum) [31], and rabbit 
anti-human ATP6V0B1 (B1) (1:500 whole serum) [22]. Tubules were then washed 
twice for 5 min with high-NaCl PBS (PBS+2.7% NaCl), once with PBS, and incubated 
with the secondary antibodies (goat anti-guinea-pig Alexa 647 1:500, donkey anti-
rabbit Alexa 594 1:1000, Jackson ImmunoResearch Laboratories Europe Ltd., 
Suffolk, UK), and DAPI at a dilution of 1:500 for 1 h at room temperature. Tubules 
were again washed twice with high-NaCl PBS and once with PBS. Cover-slips were 
mounted with Glycergel mounting medium (DakoCytomation, Glostrup, Denmark). 
Slides were examined using a Leica SP2 confocal microscope (Zurich Center for 
Microscopy and Imaging), and the images assembled with Photoshop (Adobe, San 
Jose, Calif., USA) software. 
 
Statistics 
Data are presented as mean and standard error of the mean (SEM). All data 
were tested for statistical significance using unpaired student’s t-test and results were 
considered significant if P < 0.05. 
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RESULTS 
 
Angiotensin II stimulates H+-ATPase activity 
CNT-CCD intercalated cells had an initial intracellular pH (pHi) under control 
conditions of pH 7.29 ± 0.01 (n = 36 cells in 7 CNT-CCDs)  (table 2). Removal of Na+ 
from the bath caused a slow acidification of pHi to pH 6.90 ± 0.02 which was further 
acidified after removal of an NH4Cl (20 mM) load from the bath to pH 6.54 ± 0.04   
(figure 1A). A slow alkalinization of  0.037 ± 0.003 units pH/ min. was observed in the 
nominal absence of Na+ and K+ from the bath. We and others have previously shown 
that this type of intracellular pH recovery under these conditions is mostly mediated 
by the activity of plasma membrane H+-ATPases  [12-14, 21-23, 26-28].  
Accordingly, preincubation with the H+-ATPase inhibitor concanamycin (100 
nM) [32-34] significantly reduced the rate of Na+-independent pHi recovery to 0.006 ± 
0.001 units pH/ min. demonstrating that most of the alkalinization rate was due to H+-
ATPase activity (table 2, figure 1A and 1D). The small remaining rate may be 
mediated by H+/K+-ATPase activity [35-36]. 
When the collecting tubules were preincubated with 10 nM angiotensin II for 
15 min, the initial pH (7.27 ± 0.03), the extent of acidification after Na+ removal  and 
after the NH4Cl pulse  were not altered (data not shown). However, the rate of pHi 
recovery under nominally Na+ and K+ free conditions was significantly accelerated to 
0.088 ± 0.007 pH units/ min, 2-3 times control rates (table 2, fig. 1C,D). Again, 
inhibition of H+-ATPase activity with concanamycin (100 nM) reduced the rate of pHi 
recovery to 0.009 ± 0.001 units pH/min demonstrating that increased H+-ATPase 
activity was responsible for the accelerated alkalinization in the presence of 
angiotensin II (table2, fig. 1D). 
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Angiotensin II stimulates H+-ATPase via the AT1 receptor 
 Bicabonate reabsorptipon and urinary acidification along the nephron and 
collecting duct is stimulated by angiotensin II involving the AT1 receptor subtype [13-
14, 17, 37-38]. Similarly, AT1 receptors are involved in the stimulation of bicarbonate 
secretion by the initial cortical collecting duct by angiotensin II [19]. Thus, we tested 
whether angiotensin II stimulated H+-ATPase activity via AT1 receptors in our 
preparation. Isolated CNT-CCDs were preincubated in vitro with the AT1 receptor 
antagonist saralasin (1 µM) for 5 min before angiotensin II (10 nM) was added. 
Preincubation with saralasin completely abolished the stimulatory effect of 
angiotensin II on H+-ATPase activity. The Na+-independent pHi recovery rate in the 
presence of saralasin and angiotensin II was 0.031 ± 0.007 units pH/min (table 2, 
figure 2), not significantly different from control. 
 
 
 
Angiotensin II stimulates the trafficking of H+-ATPases to the membrane 
Stimulation of H+-ATPase activity in intercalated cells by various hormones, 
acid, or CO2 is at least in part mediated by trafficking and increased expression of H+-
ATPases at the plasma membrane [1]. Disruption of the microtubular network with 
colchicine has been shown to prevent the increased expression and activity of H+-
ATPases [12, 14, 23, 39-40] in similar preparations. Here, preincubation of CNT-
CCDs in vitro with colchicine (10 µM) for 20 min before application of 10 nM 
angiotensin II completely and significantly abolished the stimulatory effect of 
angiotensin II on H+-ATPase activity (0.032 ± 0.002 units pH/min) (table 2, figure 3). 
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 We performed additional experiments with CNT-CCDs from mice expressing 
eGFP under the promoter of the B1 H+-ATPase subunit to facilitate identification of 
the respective segments. CNT-CCDs were incubated in vitro with angiotensin II and 
stained with antibodies against the B1 H+-ATPase subunit and pendrin (figure 4). In 
control CNT/CCDs, localization of the B1 H+-ATPase in pendrin positive cells was  
mostly at the basolateral pole of cells with dispersed staining at the membrane and in 
the cytosol. In CNT/CCDs incubated in vitro with angiotensin II, staining for the B1 
H+-ATPase appeared to be more membrane associated whereas no difference in 
pendrin staining was noted consistent with previous experiments [18]. 
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DISCUSSION 
 
Angiotensin II is a potent regulator of blood pressure and acid-base 
homeostasis. Angiotensin II acts on blood pressure by inducing vasoconstriction and 
stimulating renal NaCl reabsorption in the proximal tubule, distal convoluted tubule, 
and collecting duct system [37, 41-42]. In addition, angiotensin II has multiple effects 
on renal acid-base handling. Angiotensin II stimulates bicarbonate reabsorption by 
the proximal tubule, the thick ascending limb of the loop of Henle, and the distal 
convoluted tubule [10-11, 43-48]. In the late cortical collecting duct and outer 
medullary collecting duct, angiotensin II enhances proton secretion by type A 
intercalated cells [13-14, 19]. Moreover, angiotensin II also increases luminal 
alkalinization in the connecting tubule and early cortical collecting duct and directly 
stimulates chloride absorption by type B intercalated cells [18-19]. Moreover, 
stimulation of pendrin activity may also indirectly enhance electroneutral NaCl 
reabsorption via the recently described Na+-driven Cl-/HCO3- exchanger 
(NDCBE/SLC4A8) [49]. 
 
Here we demonstrate that angiotensin II in the physiological range [42, 50] 
stimulates the activity of H+-ATPases in intercalated cells in isolated mouse 
CNT/CCDs. Angiotensin II most likely acts via AT1 receptors since the AT1 receptor 
antagonist saralasin completely abolished the effect. The distribution and localization 
of angiotensin II receptors along the nephron is not completely documented but AT1 
receptors may be present both on luminal and basolateral membranes of almost all 
cells along the collecting duct system as evident from various functional experiments 
and immunolocalization studies [9, 13-14, 18-19, 37-38, 41-42, 44, 50-52].  
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Angiotensin II acting in the collecting duct may come from various sources 
including circulating and filtered angiotensin II, angiotensin II produced in the 
proximal tubule, as well as angiotensin II activated locally in the collecting duct [53]. 
Rohrwasser et al. demonstrated the existence of all major components of a local 
renin-angiotensin system in the collecting duct [52] including angiotensin-converting 
enzyme (ACE).  
Regulation of H+-ATPase activity may involve various mechanisms including 
assembly and disassembly of proton pumps, trafficking of pumps into the membrane, 
and changes in the ATP : H+-pumping coupling ratio [1, 54-55]. In type A intercalated 
cells, angiotensin II stimulates H+-ATPases by a process that requires an intact 
microtubular network sensitive to colchicine [14] and leads to an accumulation of H+-
ATPases at the luminal membrane [13]. Similarly, many other hormones or stimuli 
increase H+-ATPase trafficking and abundance at the membrane in the collecting 
duct, along the nephron, or in similar preparations [12, 23, 26, 39, 56-58]. Colchicine 
prevented the stimulation of H+-ATPase activity by angiotensin II in the CNT/CCD 
intercalated cells suggesting a similar mechanism. Immunocytochemistry of isolated 
mouse CNT/CCD fragments stimulated in vitro with angiotensin II suggested a more 
membrane associated H+-ATPase staining in cells expressing pendrin consistent with 
retention or increased trafficking of pumps into the membrane and enhanced pump 
activity. The stimulated H+-ATPase activity would then energize enhanced chloride 
absorption or luminal alkalinization via pendrin as observed in earlier studies [18-19]. 
 
In summary, angiotensin II stimulates H+-ATPase activity in isolated mouse 
CNT/CCD intercalated cells involving AT1 receptors and leading to enhanced 
membrane abundance of H+-ATPases. Increased H+-ATPase activity is a prerequisite 
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for enhancing pendrin activity by altering driving forces for bicarbonate secretion and 
chloride absorption. 
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FIGURE LEGENDS 
 
Table 1 
Composition of solutions used for functional experiments. NMDG is N-Methyl-D-
Glucamine, all solutions were titrated to pH 7.4 at 37 °C using either NaOH or KOH. 
NMDG was titrated with HCl. 
 
Table 2 
Summary of functional data from pH measurements. Data are summarized as mean 
± SEM. Shown are initial pHi in the presence of sodium, pHi recovery rates after 
removal of NH4Cl in the absence of sodium and after readdition of sodium to the 
bath, final pHi before calibration, and the number of intercalated cells and isolated 
CNT-CCDs investigated. 
 
Figure 1 
Angiotensin II stimulates H+-ATPase activity in CNT-CCD intercalated cells. (A-
C) Original tracings of intracellular pH measurements in intercalated cells in isolated 
CNT-CCD fragments under control conditions (A), during incubation with the H+-
ATPase inhibitor concanamycin (100 nM) (B), and during exposure to 10 nM 
angiotensin II (C). The rate of intracellular pH recovery (alkalinization) after removal 
of NH4Cl from the bath and in the absence of sodium was analyzed. (D) Summary of 
Na+-independent pHi recovery rates. Mean ± SEM, *** indicates p < 0.001 compared 
to control.   
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Figure 2 
The AT1 receptor antagonist saralasin prevents the stimulation by angiotensin 
II. CNT-CCDs were preincubated with the AT1 receptor antagonist saralasin (1 μM) 
and incubated with 10 nM angiotensin II. (A) Original pHi tracing of an intercalated 
cell incubated with saralasin and angiotensin II. (B) Summary of pHi recovery rates of 
intercalated cells under control conditions, angiotensin II, and saralasin with 
angiotensin II. pHi recovery rates from control and angiotensin II are taken from figure 
1 and shown for comparison. Mean ± SEM, *** indicates p < 0.001 compared to 
angiotensin II alone.   
 
Figure 3 
Stimulation of H+-ATPase activity requires an intact microtubular network. 
Isolated CNT-CCDs were preincubated with colchicine (20 µM) for 20 min prior to 
stimulation with 10 nM angiotensin II. (A) Original pHi tracing of an intercalated cell 
incubated with colchicine and angiotensin II. (B) Summary of pHi recovery rates of 
intercalated cells under control conditions, angiotensin II, and colchicine with 
angiotensin II. pHi recovery rates from control and angiotensin II are taken from figure 
1 and shown for comparison. Mean ± SEM, *** indicates p < 0.001 compared to 
angiotensin II alone.   
 
Figure 4 
Immunolocalization of H+-ATPases in pendrin expressing CNT/CCD 
intercalated cells. CNT-CCDs expressing eGFP (green) in intercalated cells were 
incubated without (left panel) or with 10 nM angiotensin II (right panel) and stained 
with antibodies against the B1 H+-ATPase subunit (red) and pendrin (yellow). Nuclei 
were visualized with DAPI (blue). Inserts show higher magnification of selected 
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intercalated cells, arrows point to intercalated cells with typical patterns of H+-ATPase 
staining. Original magnification 400 x. 
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Table 1 
 
 Standard 
HEPES 
Na+-free 
HEPES 
Na+-free 
HEPES + 
NH4Cl 
Na+ and K+-
free HEPES 
High K+ 
calibration 
NaCl 125 - - - - 
NMDG - 125 105 130 32.8 
NH4Cl - - 20 - - 
KCl 3 3 3 3 105 
MgSO4 1.2 1.2 1.2 1.2 1.2 
CaCl2 1 1 1 1 1 
KH2PO4 2 2 2 2 - 
Glucose 5 5 5 5 - 
HEPES 32.2 32.2 32.2 32.2 32.2 
pH 7.4 7.4 7.4 7.4 6.0, 7.0, 8.0 
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Table 2 
 
 Initial pHi Na+-
independent pHi 
recovery 
(∆pH/min) 
Na+-
dependent pHi 
recovery 
(∆pH/min) 
Final pHi Number 
Cells 
(tubules) 
 
Control 
 
 
7.29 ± 0.01 
 
0.037 ± 0.003 
 
0.184 ± 0.012 
 
7.24 ± 0.02 
 
36 (7) 
 
Concanamycin 
 
 
7.31 ± 0.01 
 
0.006 ± 0.001 
 
0.262 ± 0.018 
 
7.23 ± 0.02 
 
53 (5) 
 
Angiotensin II 
 
 
7.27 ± 0.03 
 
0.088 ± 0.007 
 
0.351 ± 0.031 
 
7.26 ± 0.04 
 
20 (6) 
 
Angiotensin II 
Concanamycin 
 
7.27 ± 0.01 
 
0.009 ± 0.001 
 
0.262 ± 0.039 
 
7.23 ± 0.04 
 
35 (5) 
 
Saralasin 
Angiotensin II 
 
7.29 ± 0.02 
 
0.031 ± 0.007 
 
0.189 ± 0.023 
 
7.19 ± 0.03 
  
24 (4) 
 
Colchicine 
Angiotensin II 
 
7.33 ± 0.02 
 
0.032 ± 0.002 
 
0.119 ± 0.055 
 
7.18 ± 0.02 
 
22 (4) 
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